Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TEDOR Pharma, Rhode Island Hospital in Clinical Mfg. Pact | Contract Pharma
Breaking News

TEDOR Pharma, Rhode Island Hospital in Clinical Mfg. Pact

To provide cGMP contract manufacturing services to support a clinical trial exploring the safety and efficacy of Praziquantel in children under the age of four.

TEDOR Pharma, Inc., a full-service contract development and manufacturing organization (CDMO), has entered an agreement to provide cGMP contract manufacturing services for the Center for International Health Research at Rhode Island Hospital.

TEDOR will support a clinical trial exploring the safety and efficacy of Praziquantel in children under the age of four. TEDOR is expected to serve as Rhode Island Hospital’s qualified manufacturing partner for any further development requirements.

Jennifer Friedman, MD, PhD said, “We are pleased to be working with TEDOR on this important project. Their location, capabilities, and facilities are a very good match for our program.”

“We are delighted to partner with Rhode Island Hospital to provide Phase II clinical trial manufacturing services,” said Doug Drysdale, President and CEO of TEDOR Pharma.  “Our extensive experience in manufacturing combination products makes TEDOR well suited to provide both clinical trial supply and eventual commercialization.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters